Literature DB >> 28245530

Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.

Marios E Froudarakis1, Jerôme Plojoux2,3, Elise Kaspi4,5, Stavros Anevlavis1, Sophie Laroumagne2, Georgia Karpathiou6, Elisa Roca2, Dan Adler3, Hervé Dutau2, Philippe Astoul2,7.   

Abstract

INTRODUCTION: In case of undiagnosed pleural effusions, it is necessary to conduct thoracentesis with pleural fluid (PF) cytology. Yet, sensitivity of PF cytology is widely variable as a result of sample size, experience, and preparation method.
OBJECTIVES: The aim of this study was to assess whether pleural fluid (PF) cytology is correlated to visceral or parietal pleural invasion as assessed by thoracoscopy in metastatic pleural effusions.
METHODS: All records of patients with pleural effusion were reviewed. The inclusion criteria were as follows: PF cytology, reported appearance of macroscopic pleural invasion during thoracoscopy and malignant diagnosis. Patients with mesothelioma were excluded. Finally, 287 patients who met all criteria were selected. According to the thoracoscopy findings, the extent of the disease on the pleura was analyzed in relation to the PF cytology.
RESULTS: In this study, 160 patients (55.7%) had a positive PF cytology (Group A) while 127 (44.3%) recorded negative PF cytology (Group B). From Group A, patients with visceral pleural invasion were 120 (75%) while only 49 patients (38.5%) were found from Group B and the difference was statistically significant (P < .00001). In univariate analysis, visceral pleural invasion was strongly associated with positive PF cytology (P < .001). Other significant associations with positive PF cytology included PF bloody aspect (P = .012), and endoscopic mixed pattern of pleural invasion (P = .0039). Only visceral pleural invasion was statistically significant in multivariate analysis (P < .001).
CONCLUSIONS: In patients with pleural metastatic disease, visceral pleural invasion is the only significant factor associated with positive pleural fluid cytology.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  cytology; malignant pleural effusion; thoracoscopy

Mesh:

Year:  2017        PMID: 28245530     DOI: 10.1111/crj.12619

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  4 in total

1.  Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer.

Authors:  Clement Brun; Pierre Gay; Michele Cottier; Georgia Karpathiou; Arnaud Patoir; Oliviet Tiffet; Fabrice-Guy Barral; Jean-Michel Vergnon; Marios E Froudarakis
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

2.  Prognostic role of immune microenvironment in pleural metastases from breast and lung adenocarcinomas.

Authors:  Georgia Karpathiou; Jonas Benli; Anne Laure Désage; Mathilde Jacob; Olivier Tiffet; Michel Peoc'h; Marios E Froudarakis
Journal:  Ann Transl Med       Date:  2022-04

3.  Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.

Authors:  Sachin Kolte; Sufian Zaheer; Durre Aden; Sunil Ranga
Journal:  Cytojournal       Date:  2022-09-05       Impact factor: 2.345

4.  Application of Indian Academy of Cytologists Guidelines for Reporting Serous Effusions: An Institutional Experience.

Authors:  Reetu Kundu; Radhika Srinivasan; Pranab Dey; Nalini Gupta; Parikshaa Gupta; Manish Rohilla; Shruti Gupta; Amanjit Bal; Arvind Rajwanshi
Journal:  J Cytol       Date:  2021-02-17       Impact factor: 1.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.